Arax Advisory Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$623K Buy
5,120
+2,515
+97% +$306K 0.03% 337
2025
Q1
$292K Buy
2,605
+668
+34% +$74.8K 0.02% 436
2024
Q4
$179K Buy
1,937
+1,668
+620% +$154K 0.01% 516
2024
Q3
$22.6K Buy
269
+60
+29% +$5.04K ﹤0.01% 1038
2024
Q2
$14.3K Buy
209
+93
+80% +$6.37K ﹤0.01% 1100
2024
Q1
$8.53K Sell
116
-48
-29% -$3.53K ﹤0.01% 801
2023
Q4
$13.3K Buy
164
+60
+58% +$4.88K ﹤0.01% 716
2023
Q3
$7.8K Sell
104
-13
-11% -$974 ﹤0.01% 778
2023
Q2
$9.01K Sell
117
-41
-26% -$3.16K ﹤0.01% 729
2023
Q1
$13.1K Buy
158
+42
+36% +$3.48K ﹤0.01% 646
2022
Q4
$9.98K Buy
116
+15
+15% +$1.29K ﹤0.01% 651
2022
Q3
$6K Sell
101
-145
-59% -$8.61K ﹤0.01% 747
2022
Q2
$15K Buy
246
+181
+278% +$11K ﹤0.01% 593
2022
Q1
$4K Buy
65
+36
+124% +$2.22K ﹤0.01% 822
2021
Q4
$2K Sell
29
-152
-84% -$10.5K ﹤0.01% 881
2021
Q3
$13K Buy
+181
New +$13K ﹤0.01% 606
2020
Q4
Sell
-380
Closed -$24K 742
2020
Q3
$24K Buy
+380
New +$24K ﹤0.01% 460
2018
Q4
$7K Sell
106
-349
-77% -$23K ﹤0.01% 463
2018
Q3
$35K Sell
455
-1,158
-72% -$89.1K 0.01% 328
2018
Q2
$114K Sell
1,613
-121
-7% -$8.55K 0.05% 142
2018
Q1
$130K Buy
1,734
+8
+0.5% +$600 0.07% 115
2017
Q4
$123K Sell
1,726
-11
-0.6% -$784 0.05% 132
2017
Q3
$140K Sell
1,737
-95
-5% -$7.66K 0.07% 118
2017
Q2
$129K Buy
1,832
+798
+77% +$56.2K 0.06% 133
2017
Q1
$70K Buy
1,034
+323
+45% +$21.9K 0.03% 161
2016
Q4
$51K Buy
+711
New +$51K 0.03% 165